Takeda Pharmaceutical annual operating margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Takeda Pharmaceutical Operating Margin Growth & History (TAK)
Takeda Pharmaceutical's operating margin was 10.31% for fiscal 2026.
View full Takeda Pharmaceutical company overviewTakeda Pharmaceutical annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | 10.31% | +2.83 pp |
| 2025 | 2025-03-31 | 7.48% | +2.46 pp |
| 2024 | 2024-03-31 | 5.02% | −7.16 pp |
| 2023 | 2023-03-31 | 12.18% | −0.73 pp |
| 2022 | 2022-03-31 | 12.91% | −3.01 pp |
| 2021 | 2021-03-31 | 15.93% | +12.87 pp |
| 2020 | 2020-03-31 | 3.05% | −8.28 pp |
| 2019 | 2019-03-31 | 11.33% | −2.32 pp |
| 2018 | 2018-03-31 | 13.66% | +4.66 pp |
| 2017 | 2017-03-31 | 9.00% | — |
Takeda Pharmaceutical quarterly operating margin
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2027 | 2026-06-30 | 16.51% | −0.17 pp |
| Q4 2026 | 2026-03-31 | 3.84% | — |
| Q3 2026 | 2025-12-31 | 14.17% | — |
| Q2 2026 | 2025-09-30 | 6.20% | — |
| Q1 2026 | 2025-06-30 | 16.68% | — |
Takeda Pharmaceutical operating margin trends
Over the last five fiscal years, Takeda Pharmaceutical's operating margin decreased from 15.93% to 10.31%, a change of −5.62 percentage points. The latest reported quarter, Q1 2027, shows 16.51%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Takeda Pharmaceutical source filings ↗